Skip to contentM
Myriad Genetics Inc
M
MYGNMyriad Genetics Inc Q2 2016 · 10-Q
Revenue$193.30M$193.30M+4.8% vs Q2 2015 Net Income$37.10M$37.10M+54.6% vs Q2 2015 EPS Diluted$0.50$0.50+56.3% vs Q2 2015 Operating Income$45,200,000+24.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$51,000,000+9.4% Margins · derivedOperating margin23.4%+3.7 pt vs Q2 2015
Net margin19.2%+6.2 pt vs Q2 2015
ended Dec 31, 2015 · filed Feb 3, 2016 · 34 d after period end